2015 American Transplant Congress
Immune Response to Kidney and Pancreas Self-Antigens Are Associated With Antibody Mediated Rejection in Simultaneous Kidney Pancreas Transplants
Background: Simultaneous kidney-pancreas transplantation (SKP Tx) is performed as treatment option for type-1 diabetes with end stage kidney diseases. Though allograft survival was improved with…2015 American Transplant Congress
Responsiveness to Rituximab, Plasmapheresis and Intravenous Immunoglobulins in Antibody Mediated Rejections After Kidney and Pancreas – Kidney Transplantation
The antibody-mediated rejection (AMR) has become clinically critical because this form of rejection is usually unresponsive to conventional anti-rejection therapy. Therefore, it has been recognized…2015 American Transplant Congress
Donor Obesity Impact on Simultaneous Kidney-Pancreas Transplantation Outcomes
Background: Donor obesity has been reported as a risk factor for early pancreas allograft failure. The relationship between donor obesity and long-term pancreas allograft survival…2015 American Transplant Congress
The Impact of Center Volume on Simultaneous Kidney-Pancreas Transplantation Outcomes
Background: Pancreas transplantation is associated with a high incidence of surgical complications and successful outcomes require experienced surgical and post-transplant care. Prior studies have linked…2015 American Transplant Congress
Management of Pancreas Graft Splenic Vein Thrombosis: Is Conservative Management Safe?
Background: Prophylaxis for graft portal/splenic venous thrombosis following pancreas transplant varies between institutions. Similarly, treatment of venous thrombosis ranges from early re-exploration to conservative management…2015 American Transplant Congress
Sirolimus Based Maintenance Immunosuppression in Pancreas Transplant Recipients
Surgery, The Ohio State University, Columbus, OH.
The present study evaluated the outcome of a Sirolimus based maintenance immunosuppressive protocol in pancreas transplant recipients. Between August 2003 and December 2013, a total…2015 American Transplant Congress
Safety and Efficacy of Conversion from Conventional Twice Daily Tacrolimus to Once Daily Extended Release Tacrolimus in Stable Pancreas Transplant (SPK and PAK) Recipients
Surgery, Multi-Organ Transplant, Toronto General Hospital, Toronto, ON, Canada.
Background: A once-daily, modified-release oral formulation of tacrolimus has been developed to simplify dosing and improve medication adherence. There is limited data on the implementation…2015 American Transplant Congress
Donors at Age Extremes for Simultaneous Pancreas-Kidney Transplant (SPKT)
Background:Shortage of optimal pancreatic donors stimulates a search for options to expand the donor pool. Extreme age donors ( <13 yrs or > 50 yrs…2015 American Transplant Congress
Import Pancreas Transplants: Good from Far or Far from Good?
General Surgery-Transplantation, Wake Forest Baptist Medical Center, Winston-Salem, NC.
Background: Many transplant (tx) programs are reluctant to import pancreas allografts because of concerns that outcomes might be inferior to locally procured organs. Methods: Single…2015 American Transplant Congress
Simultaneous Cadaveric Pancreas, Living-Donor Kidney Transplantation: Single Center Experience
Surgery and Organ Transplant Center, Asan Medical Center, Seoul, Korea.
BackgroundSimultaneous cadaveric pancreas and living-donor kidney transplantation(SPLK) is an attractive approach for uremic Type I diabetic patients, due to its distinct advantages from living kidney…
American Transplant Congress abstracts